Fig. 6. Summary of clinicopathological and molecular characteristics of classes of mesenchymal neoplasms with DICER1 alteration.
LOF Loss of function, LOH Loss of heterozygosity.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.